These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18725441)

  • 1. In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
    Fernández-Roblas R; Martín-de-Hijas NZ; Fernández-Martínez AI; García-Almeida D; Gadea I; Esteban J
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4184-6. PubMed ID: 18725441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epsilometer test for determining in-vitro activity of tigecycline against rapidly growing mycobacteria from central Saudi Arabia.
    Al-Ateah SM; Omrani AS; Bakheshwain SM
    Saudi Med J; 2013 May; 34(5):542-3. PubMed ID: 23677274
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of the Etest for studying tigecycline susceptibility of non-pigmented rapidly growing mycobacteria.
    Martín-de-Hijas NZ; Fernández-Roblas R; Fernandez-Martínez AI; Gadea I; Esteban J
    Int J Antimicrob Agents; 2008 Oct; 32(4):366-7. PubMed ID: 18572391
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C; Gurpinar T; Ecemis T
    New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of tigecycline (GAR-936) and 12 other antimicrobial agents against 90 Eikenella corrodens clinical isolates.
    Cercenado E; Cercenado S; Bouza E
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2644-5. PubMed ID: 12878532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
    Arroyo LA; Mateos I; González V; Aznar J
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.
    Cercenado E; Marín M; Sánchez-Martínez M; Cuevas O; Martínez-Alarcón J; Bouza E
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1102-4. PubMed ID: 17194827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
    Petrini B
    APMIS; 2006 May; 114(5):319-28. PubMed ID: 16725007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
    Fernandez-Roblas R; Adames H; Martín-de-Hijas NZ; Almeida DG; Gadea I; Esteban J
    Int J Antimicrob Agents; 2009 May; 33(5):453-5. PubMed ID: 19153032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia.
    Dhabaan GN; AbuBakar S; Shorman MA; Hassan H
    J Chemother; 2012 Apr; 24(2):87-92. PubMed ID: 22546763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Pythium insidiosum isolates to aminoglycoside antibiotics and tigecycline.
    Mahl DL; de Jesus FP; Loreto É; Zanette RA; Ferreiro L; Pilotto MB; Alves SH; Santurio JM
    Antimicrob Agents Chemother; 2012 Jul; 56(7):4021-3. PubMed ID: 22508303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of antibiotic activity against Mycobacterium abscessus.
    Lerat I; Cambau E; Roth Dit Bettoni R; Gaillard JL; Jarlier V; Truffot C; Veziris N
    J Infect Dis; 2014 Mar; 209(6):905-12. PubMed ID: 24253289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002.
    Bouchillon SK; Hoban DJ; Johnson BM; Stevens TM; Dowzicky MJ; Wu DH; Bradford PA
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):291-5. PubMed ID: 15808321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
    Liu CY; Huang YT; Liao CH; Hsueh PR
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2677-9. PubMed ID: 18474585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria.
    Esteban J; Martín-de-Hijas NZ; Ortiz A; Kinnari TJ; Bodas Sánchez A; Gadea I; Fernández-Roblas R
    Int J Antimicrob Agents; 2009 Nov; 34(5):454-6. PubMed ID: 19665358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
    Denis O; Deplano A; Nonhoff C; Hallin M; De Ryck R; Vanhoof R; De Mendonça R; Struelens MJ
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2680-5. PubMed ID: 16870758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
    Salas C; Calvo J; Martínez-Martínez L
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1503-5. PubMed ID: 18227183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.